➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Harvard Business School
McKinsey
AstraZeneca
Baxter

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

PERRIGO UK FINCO Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PERRIGO UK FINCO, and what generic and branded alternatives to PERRIGO UK FINCO drugs are available?

PERRIGO UK FINCO has twenty-six approved drugs.

There are two tentative approvals on PERRIGO UK FINCO drugs.

Summary for PERRIGO UK FINCO
US Patents:0
Tradenames:20
Ingredients:20
NDAs:26

Drugs and US Patents for PERRIGO UK FINCO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Uk Finco CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE betamethasone dipropionate; calcipotriene SUSPENSION;TOPICAL 212367-001 Sep 11, 2020 AB RX No No   Get Started Free   Get Started Free
Perrigo Uk Finco TRIAMCINOLONE ACETONIDE triamcinolone acetonide SPRAY;TOPICAL 205782-001 Apr 13, 2015 AT RX No No   Get Started Free   Get Started Free
Perrigo Uk Finco SUMATRIPTAN sumatriptan SPRAY;NASAL 213465-001 Sep 21, 2020 AB RX No No   Get Started Free   Get Started Free
Perrigo Uk Finco SUMATRIPTAN sumatriptan succinate SPRAY;NASAL 213465-002 Sep 21, 2020 AB RX No No   Get Started Free   Get Started Free
Perrigo Uk Finco DICLOFENAC SODIUM diclofenac sodium GEL;TOPICAL 211253-001 May 16, 2019 OTC No No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Dow
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.